WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by...
TheraVet (Paris:ALVET) (Brussels:ALVET) (ISIN: BE0974387194 - ticker: ALVET), a biotech company developing pioneering treatments for osteoarticular disease in pets, announced today the signature of...
InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the first patient in China has been dosed in clinical trial...
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has agreed to acquire the Canadian assets of Teligent Inc. (Teligent) for $45.75...
Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address critical problems in public health—from the opioid crisis to the Covid-19 pandemic, as well...
